TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

High-throughput DNA sequence analysis was used to screen for TET2 mutations in bone marrow-derived DNA from 239 patients with BCR-ABL-negative myeloproliferative neoplasms (MPNs). Thirty-two mutations (19 frameshift, 10 nonsense, 3 missense; mostly involving exons 4 and 12) were identified for an ov...

Full description

Saved in:

Bibliographic Details
Published in:	Leukemia
Main Authors:	Tefferi, A, Pardanani, A, Lim, K-H, Abdel-Wahab, O, Lasho, TL, Patel, J, Gangat, N, Finke, CM, Schwager, S, Mullally, A, Li, C-Y, Hanson, CA, Mesa, R, Bernard, O, Delhommeau, F, Vainchenker, W, Gilliland, DG, Levine, RL
Format:	Artigo
Language:	Inglês
Published:	2009
Subjects:	Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4654629/ https://ncbi.nlm.nih.gov/pubmed/19262601 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2009.47
Tags:	Add Tag No Tags, Be the first to tag this record!

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

Similar Items